Potential modifications to the risk-adjustment model used for the Affordable Care Act commercial plans could improve the model and appropriately compensate plans that enroll sicker enrollees.
Potential modifications to the risk-adjustment model used for the Affordable Care Act (ACA) commercial plans could improve the model and appropriately compensate plans that enroll sicker enrollees, according to a new report from Avalere Health. This change would encourage plans to compete based on cost, quality, and health management.
The report, “Evolving the Risk-Adjustment Model to Improve Payment Accuracy in the Individual & Small Group Market,” examines the risk-adjustment program used for the ACA in the commercial market, provides an analysis of the limitations facing the current model, and suggests potential modifications that could improve it.
The ACA created a risk-adjustment program to promote accuracy for health plans by appropriately compensating plans for the financial costs of their enrollees, the report explains. The risk adjustment allows the plans to receive a higher payment for sicker enrollees with costlier care and a lower payment for healthier enrollees, whose care costs less. The goal of the risk-adjustment program is to encourage insurers to compete based on the efficiency and value of their plans, as opposed to attracting healthier enrollees.
“If the risk-adjustment model is inaccurate, then plans that enroll a disproportionate share of sicker enrollees may experience financial losses and exit the market, even if they have priced premiums accurately,” said Tom Kornfield, vice president of Avalere. “By appropriately compensating plans, an accurate model encourages plans to compete based on cost, quality, and health management.”
Limitations to Existing ACA Risk-Adjustment Model
The report identifies 3 main limitations of the existing risk-adjustment model for the individual and small-group market:
The Avalere report concludes that the unique characteristics of the exchange and individual market populations are not being adequately accounted for in the existing risk-adjustment model, so changes should be made to the model to ensure that health plans have an incentive to remain participants in the exchange market.
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen